Business description: Vical Incorporated

Fresh Tracks Therapeutics, Inc. is not engaged in any business activities. The Company is in the process of dissolution.

Sales by Activity: Vical Incorporated

Fiscal Period: December 2019 (USD) 2020 (USD) 2021 (USD) 2022 (USD) 2023 (USD)

Pharmaceuticals

7.92M 1.82M 404K 6.94M 8.01M

Geographical breakdown of sales: Vical Incorporated

Fiscal Period: December 2019 (USD) 2020 (USD) 2021 (USD) 2022 (USD) 2023 (USD)

United States

7.92M 1.82M 404K 6.94M 8.01M

Executive Committee: Vical Incorporated

Manager TitleAgeSince
Chief Executive Officer 74 -
Chief Tech/Sci/R&D Officer - 2015-12-31
Director of Finance/CFO - 2022-05-31
Corporate Officer/Principal - -
Human Resources Officer - -

Company details: Vical Incorporated

Fresh Tracks Therapeutics, Inc.

5777 Central Avenue

80301, Boulder

+

http://www.frtx.com
address Vical Incorporated

Bio Therapeutic Drugs

Change 5-day change 1-year change 3-year change Capi.($)
-2.49%-3.76%+50.31%+62.10% 63.66B
-0.63%-2.91%+6.20%+89.22% 58.56B
-2.37%-2.22%+22.87%+82.31% 54.19B
-2.19%-6.15%+11.92%+108.08% 44.66B
-1.89%-7.28%+13.22%+19.74% 40.51B
-0.93%-0.47%+19.73%+43.75% 36.27B
+1.11%-6.44%+130.68%+641.83% 34.89B
-0.80%+0.61%+77.26%+56.26% 32.26B
-2.17%+16.65%-29.21%+474.05% 31.01B
Average -1.37%-1.22%+33.67%+175.26% 44B
Weighted average by Cap. -1.48%-1.85%+32.16%+150.90%
  1. Stock Market
  2. Stocks
  3. FRTX Stock
  4. Stock
  5. Company Vical Incorporated